Process for preparing a substituted imidazopyridine compound

专利摘要:
The present invention comprises the step of reacting a compound of Formula 2 with a 3-halo-2-butanone compound in cyclohexanone, wherein R 1 is a C 1 -C 6 alkoxy group or NH 2 group substituted imidazo Provided are novel methods for the preparation of large amounts of pyridine compounds.
公开号:KR20030032011A
申请号:KR10-2003-7003311
申请日:2001-09-05
公开日:2003-04-23
发明作者:비외른 엘만；질케 에르박크；에릭 티에메르만
申请人:아스트라제네카 아베；
IPC主号:

专利说明:

Process for preparing substituted imidazopyridine compound {PROCESS FOR PREPARING A SUBSTITUTED IMIDAZOPYRIDINE COMPOUND}
[2] The present invention relates to a novel process suitable for the preparation of large amounts of substituted imidazopyridine compounds of formula (I) comprising the step of reacting a compound of formula (II) with a 3-halo-2-butanone compound in cyclohexanone .
[3]
[4]
[5] In the formula,
[6] R ¹ is a C ₁ -C ₆ alkoxy group or NH ₂ group.
[7] A substituted aminopyridine compound of formula Wherein X is H, CH ₃ or an ester group such as COOCH ₃ or COOC ₂ H ₅ , Y is CH ₃ and CH ₂ CH ₃ and Z is a leaving group such as halogen, mesyl or tosyl By reaction with Similar reactions yielding compounds of formula X and Y as defined above are described in WO 99/55706, EP 33094, 204 285, 228 006 and 308. 917.
[8]
[9] This reaction is preferably carried out at an elevated temperature in an inert solvent such as acetone, alcohol, benzene, N, N-dimethylformamide, tetrahydrofuran, chloroform or diethyl ether, optionally in the presence of an inorganic or organic base.
[10] This reaction is characterized by long reaction times such as 16 to 84 hours, high reaction temperatures and relatively low yields such as 22% to 55%. Thus, the reaction is not suitable for the preparation of large amounts of substituted imidazopyridine compounds.
[11] The inventors have surprisingly found that when the method of the present invention is carried out as described herein, the reaction time can be shortened, the reaction temperature can be lowered, and the yield can be improved.
[1] The present invention provides a novel process for the preparation of substituted imidazopyridine compounds, more particularly for the preparation of 2,3-dimethylimidazo [1,2-a] pyridine, in which the 6-position is substituted with a carboxamido group or a carboxyalkyl group It is about. Further aspects of the invention also relate to novel intermediates used in the process.
[12] The present invention provides a novel method for the preparation of large amounts of substituted imidazopyridine compounds of formula (I) comprising the step of reacting a compound of formula (II) with a 3-halo-2-butanone compound in cyclohexanone.
[13] <Formula 1>
[14]
[15] <Formula 2>
[16]
[17] In the formula,
[18] R ¹ is a C ₁ -C ₆ alkoxy group or NH ₂ group.
[19] A first embodiment of the present invention is to react a compound of formula 2 with a 3-halo-2-butanone compound in cyclohexanone to obtain a compound of formula 1 below.
[20] <Formula 1>
[21]
[22] <Formula 2>
[23]
[24] In the formula,
[25] R ¹ is a C ₁ -C ₆ alkoxy group.
[26] A second embodiment of the present invention is to react a compound of formula 2 with a 3-halo-2-butanone compound in cyclohexanone to obtain a compound of formula 1 below.
[27] <Formula 1>
[28]
[29] <Formula 2>
[30]
[31] In the formula,
[32] R ¹ is an NH ₂ group.
[33] The process of the invention dissolves or suspends a compound of formula (2) in cyclohexanone, adds a 3-halo-2-butanone compound, heats the reaction for several hours, and then a compound of formula (1) It is carried out by isolating in high yield.
[34] <Formula 1>
[35]
[36] <Formula 2>
[37]
[38] In the formula,
[39] R ¹ is a C ₁ -C ₆ alkoxy group or NH ₂ group.
[40] The amount of cyclohexanone is not critical to the practice of the present invention and can be adjusted according to the needs and equipment used in the field. It is also possible to mix cyclohexanone with an inert solvent such as ether. Examples of suitable inert solvents include, but are not limited to, tetrahydrofuran (THF). The amount of inert solvent can be up to about 50% by volume without lowering the yield.
[41] The amount of 3-halo-2-butanone compound is not critical for carrying out the present invention. The amount of 3-halo-2-butanone compound is 1.1 to 5 molar equivalents, preferably 1.1 to 2 molar for practical and economic reasons. Equivalent weight is added. Examples of suitable 3-halo-2-butanone compounds include, but are not limited to, 3-bromo-2-butanone and 3-chloro-2-butanone. desirable.
[42] The reaction temperature and reaction time may vary depending on the actual needs. The reaction temperature is preferably 80 ° C to 100 ° C. The reaction temperature is the temperature that allows the reaction to complete in a few hours, such as 1 to 4 hours. The conversion is generally above 95% and the isolation yield is generally above 70%.
[43] Starting materials for use in the present invention may be prepared as disclosed in WO 99/55706 or alternatively as described in Scheme 1 below.
[44]
[45] Step i
[46] The compound of formula 3 in Scheme 1 is treated with thionyl chloride, or any equivalent reagent, in an appropriate solvent for several hours at elevated temperature to yield the corresponding chloride compound. The reaction is carried out using about 1 to 5 equivalents, preferably 1 to 2.5 equivalents of thionyl chloride in toluene at about 100 ° C. for 2 to 8 hours. The corresponding chloride compound is then treated with 2 to 25 equivalents, preferably 3 to 12 equivalents of ammonia in the same solvent as above at approximately ambient temperature to afford the compound of formula 4 above.
[47] Step ii
[48] The compound of Chemical Formula 4 in Scheme 1 is hydrogenated in an aqueous alcoholic solution using a catalyst to obtain the compound of Chemical Formula 5. Examples of suitable catalysts include, but are not limited to, palladium, ruthenium or mixtures thereof. Pd-Ru / C paste is the preferred catalyst. Examples of alcohols include, but are not limited to, methanol, ethanol and propanol, with methanol being preferred.
[49] The substituted imidazopyridine compound of formula (I) to manufacture according to the invention is that after the gastrointestinal H ^+, K ⁺ -ATPase inhibitor is then be used in the preparation of imidazopyridine derivatives of certain substituted particularly effective as inhibitors of gastric acid secretion have.
[50] <Formula 1>
[51]
[52] In the formula,
[53] R ¹ is a C ₁ -C ₆ alkoxy group or NH ₂ group.
[54] The compound of formula 1 may be reacted with a compound of formula 6 to obtain a compound of formula 7.
[55]
[56]
[57] In the formula,
[58] R ¹ is as defined above,
[59] R ³ is H, C ₁ -C ₆ alkyl, hydroxylated C ₁ -C ₆ alkyl or halogen;
[60] R ⁴ is H, C ₁ -C ₆ alkyl, hydroxylated C ₁ -C ₆ alkyl or halogen;
[61] R ⁵ is H or halogen;
[62] Y is a leaving group such as a halide, tosyl group or mesyl group.
[63] It is convenient to carry out this reaction with or without a base in an inert solvent such as acetone, acetonitrile, dimethoxyethane, methanol, ethanol or dimethylformamide. Bases include, for example, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkali metal carbonates such as potassium carbonate and sodium carbonate; Or organic amines such as triethylamine.
[64] Thereafter, the compound of formula 7 wherein R ¹ is C ₁ -C ₆ alkoxy may be further reacted with the amino compound of formula 8 to obtain the corresponding amide compound.
[65]
[66] In the formula,
[67] R ⁶ and R ⁷ are the same as or different from each other, H, C ₁ -C ₆ alkyl, hydroxylated C ₁ -C ₆ alkyl, C ₁ -C ₆ alkoxy-substituted C ₁ -C ₆ alkyl, hydroxide Oxylated C ₁ -C ₆ alkoxy-substituted C ₁ -C ₆ alkyl and aryl.
[68] R ⁶ and R ⁷ together with the nitrogen atom to which they are attached may form a saturated or unsaturated ring containing optionally one or more additional heteroatoms such as to form morpholine, piperazine, pyrrolidine or piperidine have.
[69] The reaction can be carried out by dissolving in an inert solvent under standard conditions or by heating the reactants in the pure amino compound.
[70] Alternatively, the compound of formula (7) may be hydrolyzed to the corresponding carboxylic acid compound of formula (9) under standard conditions.
[71] <Formula 7>
[72]
[73]
[74] In the formula,
[75] R ³ , R ⁴ and R ⁵ are as defined above,
[76] R ¹ is an NH ₂ group.
[77] Thereafter, the compound of formula 9 can be reacted with an amino compound of formula 8 in the presence of a coupling agent to give the corresponding amide compound.
[78] <Formula 8>
[79]
[80] In the formula,
[81] R ⁶ and R ⁷ are as defined above.
[82] The reaction can be carried out in an inert solvent under standard conditions.
[83] Example 1.1
[84] Preparation of Bromobutanone
[85] In the reactor, sodium bromide (84 kg) was suspended in dimethylformamide (125 L). 3-chloro-2-butanone (85 kg) was added at 15 ° C to 30 ° C. Stirring was continued for 4 hours and then filtered. The filter cake was washed with cyclohexanone (38 L). The bromobutanone thus prepared is ready for use in the cyclization step.
[86] Example 1.2
[87] Synthesis of Methyl 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate
[88]
[89] Bromobutanone (1.2 equiv, 3.9 ml) was added over 10 minutes to a suspension of 5,6-diamino-nicotinic acid methyl ester (1 equiv, 5.1 g) in cyclohexanone (50 ml). The mixture was heated to 100 ° C (internal temperature) and stirred at this temperature for 2.5 hours. The mixture was cooled to room temperature and the pale solid was filtered off and washed with TBME (3 × 10 ml). It dried at 45 degreeC under reduced pressure. Yield: 6.53 g (75%).
[90] Example 1.3
[91] Synthesis of ethyl 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate
[92]
[93] Bromobutanone (1.4 equivalent, 5.95 g) was added over 15 minutes to a suspension of 5,6-diamino-nicotinic acid ethyl ester (1 equiv, 5.0 g) in cyclohexanone (50 ml). The dark brown mixture was heated to 100 ° C. (internal temperature) and stirred at this temperature for 1.5 hours. The mixture was cooled to room temperature and the pale brown solid was filtered off and washed with TBME (20 ml). It dried at 45 degreeC under reduced pressure. Yield: 5.06 g (65%).
[94] Example 1.4
[95] Synthesis of Isopropyl 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate
[96]
[97] Bromobutanone (1.2 equiv, 3.4 ml) was added over 10 minutes to a suspension of 5,6-diamino-nicotinic acid isopropyl ester (1 equiv, 5.1 g) in cyclohexanone (50 ml). The dark brown mixture was heated to 100 ° C. (internal temperature) and stirred at this temperature for 1.5 hours. The suspension was cooled to room temperature and the pale yellow solid was filtered off and washed with TBME (3 × 10 ml). It dried at 45 degreeC under reduced pressure. Yield 6.0 g (74%).
[98] Example 1.5
[99] Synthesis of 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxamide
[100]
[101] 5,6-Diamino-nicotinamide (50 g, 0.313 mol (analysis: 95.4%), 1.0 equiv) was suspended in cyclohexanone (250 ml). The suspension was heated to 100 ° C. The filtrate (bromobutanone in cyclohexanone) was added at 100 ° C. over 1 hour 10 minutes. Heating was continued for 3 hours, after which the heating source was removed. The reaction mixture was cooled to 20 ° C and stirred at this temperature for a further 2 hours. The solid was filtered off, washed carefully with TBME (2 × 330 ml) and dried to give 70.3 g of the title compound. Yield: 70%.
[102] Example 1.6
[103] Synthesis of 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxamide
[104]
[105] NaBr (27.0 g; 0.259 mol; 1.33 equiv) was suspended in cyclohexanone (220 ml) and 3-chloro-2-butanone (25.7 ml; 0.242 mol; 1.24 equiv) was added in one portion. The mixture was heated to 80 ° C and stirred for 3 hours. The mixture was cooled to 50 ° C. and the white solid was filtered off and washed with cyclohexanone (60 ml). 5,6-Diamino-nicotinamide (30 g; 0.1946 mol; 1.0 equiv) was added to the filtrate and the mixture was heated to 100 ° C. for 4 hours, after which 98% conversion was determined by HPLC. The reaction mixture was cooled to 20 ° C and stirring was continued at 20 ° C for 2 hours. The solid was filtered off, washed with TBME (220 ml) and dried to give 46.6 g of the title compound. Yield: 73%.
[106] Example 1.7
[107] Synthesis of 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxamide
[108]
[109] 5,6-Diamino-nicotinamide (30.0 g; 0.183 mol; 1.0 equiv) was suspended in cyclohexanone (280 ml). 3-bromo-2-butanone (24 ml; 0.22 mol; 1.2 equiv) was added and the mixture was heated to 100 ° C for 4 h. The reaction mixture was cooled to 20 ° C and stirred for a further 2 hours. The solid was filtered off, washed with TBME (200 ml) and dried to give 48.4 g of the title compound. Yield 78%.
[110] Example 1.8
[111] Synthesis of Methyl 2,3-dimethyl-8- (2,6-dimethylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxylate
[112]
[113] Methyl 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate (0.8 g, 3.6 mmol), 2,6-dimethylbenzylchloride (0.57 g, 3.7 mmol), Sodium carbonate (1.0 g, 9.4 mmol) and catalytic amount of potassium iodide were added to acetonitrile (10 ml) and refluxed for 20 hours. Then it was filtered, the salt was washed with methylene chloride and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography on silica gel using methylene chloride: ethyl acetate (75:25) as eluent. The yellow residue was treated with hexane to give 0.23 g (19%) of the title product.
[114] Example 1.9
[115] Synthesis of ethyl 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxylate
[116]
[117] Ethyl 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate (0.7 g, 3.0 mmol), 2-ethyl-6-methylbenzylchloride (0.5 g, 3.0 mmol ), Sodium carbonate (0.64 g, 6.0 mmol) and catalytic amount of potassium iodide were added to acetone (50 ml) and refluxed for 20 hours. It was then filtered and the acetone was evaporated under reduced pressure to give an oil. Purification of the oily product by column chromatography on silica gel using diethyl ether: petroleum ether (1: 1) as eluent gave 0.12 g (9%) of the title product.
[118]
[119] Example 1.10
[120] Synthesis of 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -N-propyl-imidazo [1,2-a] pyridine-6-carboxamide
[121]
[122] Ethyl 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxylate (0.12 g, 0.33 mmol), propylamine (1.0 g , 17 mmol) and a catalytic amount of sodium cyanide were refluxed in methanol (20 ml) for 24 hours. Additional amount of propylamine (1.0 g, 17 mmol) was added and the reaction mixture was refluxed for 24 hours. The solvent was evaporated under reduced pressure and the residue was purified by column chromatography on silica gel using diethyl ether as eluent. Crystallization from diethyl ether gave 0.053 g (42%) of the title compound.
[123]
[124] Example 1.11
[125] Synthesis of 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxamide
[126]
[127] 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxamide (3.3 g, 16.2 mmol), 2-ethyl-6-methylbenzylchloride (2.73 g, 16.2 mmol) , Potassium carbonate (8.0 g, 58 mmol) and potassium iodide (1.1 g, 6.6 mmol) were added to acetone (150 ml) and refluxed for 20 hours. Additional amount of 2-ethyl-6-methylbenzylchloride (1.0 g, 5.9 mmol) was added and the reaction mixture was refluxed for 7 hours. Methylene chloride (60 ml) and methanol (30 ml) were added. The reaction mixture is filtered and the solvent is evaporated under reduced pressure. The residue was purified by column chromatography on silica gel using methylene chloride: methanol (100: 7) as eluent. Crystallization from ethyl acetate gave 2.8 g (50%) of the title compound.
[128]
[129] Example 1.12
[130] Synthesis of 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxylic acid
[131]
[132] 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxamide mesylate (11.0 g, 0.025 mol) and sodium hydroxide (7.0 g, 0.17 mol) was dissolved in ethanol (95%) (120 ml) and refluxed for 20 hours. The solvent was evaporated under reduced pressure and water (150 ml) was added to the residue. Concentrated solids were adjusted to 5 by addition of concentrated HCl and acetic acid, and the precipitated solid was isolated by filtration, washed with water and acetone and dried to give 7.6 g (88%) of the title compound.
[133]
[134] Example 1.13
[135] Synthesis of 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -6- (morpholinocarbonyl) -imidazo [1,2-a] pyridine
[136]
[137] 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxylic acid (0.15 g, 0.44 mmol) and o-benzotriazole- 1-yl-N, N, N ', N'-tetramethyluronium tetrafluoroborate (TBTU) (0.14 g, 0.44 mmol) was added to methylene chloride (10 ml). Morpholine (0.12 g, 1.4 mmol) was added and the reaction mixture was stirred at ambient temperature for 1.5 hours. The reaction mixture was added to a column using silica gel and purified by chromatography using ethyl acetate: methylene chloride (1: 1) as eluent to afford 0.12 g (66%) of the desired product.
[138]
[139] Example 1.14
[140] Of (2-ethyl-6-methylbenzylamino) -N (2- (2-hydroxyethoxy) ethyl) -2,3-dimethylimidazo [1,2-a] pyridine-6-carboxamide synthesis
[141]
[142] 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxylic acid (0.3 g, 0.88 mmol) and o-benzotriazole- 1-yl-N, N, N ', N'-tetramethyluronium tetrafluoroborate (TBTU) (0.29 g, 0.90 mmol) was added to methylene chloride (10 ml). 2- (2-aminoethoxy) ethanol (0.2 g, 1.9 mmol) was added and the reaction mixture was stirred at ambient temperature for 2 hours. The solvent was evaporated under reduced pressure and the residue was purified by column chromatography on silica gel using methylene chloride: methanol (9: 1) as eluent. Crystallization from diethyl ether gave 0.24 g (80%) of the desired product.
[143]
[144] Example 1.15
[145] Synthesis of Isopropyl 8-[(2,6-dimethylbenzyl) amino] -2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate
[146]
[147] Isopropyl 8-amino-2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate (9.85 kg, 1.0 equiv, 29.71 mol) is suspended in isopropanol (59 L) and NaI ( 0.6 equiv, 2.68 kg, 17.88 mol) and K ₂ CO ₃ (2.5 equiv, 10.29 kg, 74.48 mol) were added and the mixture was heated to about 70 ° C. 2,6-dimethylbenzyl chloride (1.1 equiv, 5.22 kg, 32.77 mol) was dissolved in isopropanol (about 60 L) and this solution was added to the reaction mixture. After the addition was complete, the temperature was held at 60 ° C. for an additional 1.5 hours. Additional K ₂ CO ₃ (9.15 kg) was added and the resulting suspension was stirred at 60 ° C. for a further 2 hours. After addition of 2,6-dimethylbenzyl chloride (2.76 kg) in isopropanol (22 L) slowly at 60 ° C., the reaction mixture was stirred at this temperature for a further 4 hours. The suspension was diluted with water (124 L), cooled, stirred and filtered. The filtercake was washed with water, then with cooled isopropanol and dried at 40 ° C. under reduced pressure to give 11.37 kg of the wet product (yield: 90%).
[148] Example 1.16
[149] Synthesis of 8-[(2,6-dimethylbenzyl) amino] -N- (2-hydroxyethyl) -2,3-dimethylimidazo [1,2-a] pyridine-6-carboxamide
[150]
[151] Reactor isopropyl 8-[(2,6-dimethylbenzyl) amino] -2,3-dimethylimidazo [1,2-a] pyridine-6-carboxylate (11.30 kg, 1 equiv, 27.02 mol) And THF (45 L) and ethanolamine (18.97 kg, 11 equiv, 309.2 mol) were added at about 20 ° C. The suspension was heated to about 100 ° C. Some solvent was distilled off, then THF (35 L) was added and distillation was continued. THF was added and distillation was repeated until conversion was complete. Ethanol (140 L) was added to the suspension and the suspension was heated to reflux. Further ethanol (13 L) was added to obtain a clear solution. The hot solution was filtered off and then cooled. The white solid was filtered off, washed with ethanol and dried to give the product (8271 g) as a white powder.
[152] 2. Preparation of Starting Material
[153] Example 2.1
[154] Synthesis of 6-amino-5-nitro-nicotinamide
[155] 100 g of 6-hydroxy-5-nitro-nicotinic acid (0.54 mol; HPLC> 98% region) was suspended in toluene (750 ml). DMF (1 ml, 0.013 mol, 0.024 equiv) was added and the mixture was heated to 110 ° C. (internal temperature). Thionylchloride (99 ml, 2.5 equiv) was added over 120 minutes. Heating was continued at 110 ° C. for 4 hours. The reaction mixture was concentrated to 1/2 of the volume (400 ml of solvent was distilled off) and toluene (400 ml) was added. This procedure was repeated once more (400 ml of toluene was distilled off and 410 ml of fresh toluene was added again). The solution was then cooled to 20 ° C. and slowly added to aqueous ammonia (25%, 440 ml, 12 equiv) over 40 minutes. Immediately, precipitation began. During the addition, the temperature was kept below 15 ° C. After complete addition, the reaction mixture was allowed to warm to room temperature and stirring was continued for 16 hours. The solids were filtered off, washed with water (500 ml), ethanol (250 ml), TBME (250 ml) and dried (50 to 10 millibars, 40 ° C. bath temperature, 16 hours) 91.3 g of the title compound. (0.501 mol, 87%) was obtained.
[156] Example 2.2
[157] Synthesis of 5,6-diamino-nicotinamide
[158] 44.5 g (0.24 mol; HPLC: 93% region) of 6-amino-5-nitro-nicotinamide was suspended in methanol / water 1: 1 (500 ml) and the catalyst [Pd (4%)-Ru (1%) / C paste (62% H ₂ 0 type: 485; Johnson Matthey); Type: 485; Johnson Marty] 5.0 g was added. Hydrogenation was carried out at 5 bar and 30 ° C. for 5 hours. After completion, the catalyst was filtered off and washed with methanol / water 1/1 (50 ml). 480 ml of solvent were distilled off. The resulting suspension was cooled to 20 ° C and filtered off. The solid was washed with methanol (20 ml) and TBME (30 ml). Drying (200 to 10 millibars; 40 ° C. bath temperature, 16 hours) gave 27.3 g of the title compound (0.18 mol, 73%).
[159] Example 2.3
[160] Synthesis of 5,6-diamino-nicotinamide
[161] 42.3 g of 6-amino-5-nitro-nicotinamide (0.23 mol, HPLC: 93% region) was suspended in methanol / water 1: 1 (500 ml). Catalyst [Pd (5%) / C (57.8% H ₂ O); Type: 39, Johnson Marty] 5.2 g was added. Hydrogenation was carried out at 5 bar and 30 ° C. for 4 hours. After completion the catalyst was filtered off and washed with methanol / water 1/1 (100 ml). 550 ml of solvent were distilled off. The resulting suspension was cooled to 20 ° C and filtered off. The solid was washed with methanol (20 ml) and TBME (30 ml). Drying (200 to 10 millibars; 40 ° C. bath temperature, 16 hours) gave 28.5 g of the title compound (0.18 mol, 78%).

权利要求:
Claims (10)
[1" claim-type="Currently amended] A process for preparing a substituted imidazopyridine compound of Formula 1, comprising reacting a compound of Formula 2 with a 3-halo-2-butanone compound in cyclohexanone.
<Formula 1>

<Formula 2>

In the formula,
R ¹ is C ₁ -C ₆ alkoxy or NH ₂ .
[2" claim-type="Currently amended] The method of claim 1, wherein the 3-halo-2-butanone compound is 3-bromo-2-butanone or 3-chloro-2-butanone.
[3" claim-type="Currently amended] The method according to claim 1 or 2, wherein the amount of 3-halo-2-butanone compound is 1.1 to 5 molar equivalents.
[4" claim-type="Currently amended] The process of claim 1 wherein the reaction temperature is from 80 ° C. to 100 ° C.
[5" claim-type="Currently amended] The method of claim 1 wherein the cyclohexanone is diluted with an inert solvent.
[6" claim-type="Currently amended] The method of claim 1, wherein R ¹ is C ₁ -C ₆ alkoxy.
[7" claim-type="Currently amended] The method of claim 1, wherein R ¹ is NH ₂ .
[8" claim-type="Currently amended] The method of claim 1, wherein the compound of formula 2 is prepared by a method comprising using a catalyst and hydrogenating the compound of formula 4 in an aqueous alcoholic solution.
<Formula 4>

[9" claim-type="Currently amended] The method of claim 8, wherein the catalyst is a Pd-Ru / C paste.
[10" claim-type="Currently amended] 10. The method of claim 8 or 9, wherein the compound of formula 4 is prepared by a method comprising treating the compound of formula 3 with thionyl chloride to obtain a corresponding chloride compound, followed by treatment with ammonia. How to.
<Formula 3>

类似技术:

---

公开号 | 公开日 | 专利标题

---

CA2104781C|2002-07-09|Process for imidazo[4,5-c]quinolin-4-amines

---

KR102065319B1|2020-01-10|Substituted heterocycle fused gamma-carbolines synthesis

---

EP2079721B1|2010-07-28|Process for the preparation of |-4-fluoromethyl-dihydro-furan-2-one

---

JP5202635B2|2013-06-05|Processes and intermediates for the preparation of integrase inhibitors

---

DE69937077T2|2008-05-29|Intermediates for the preparation of imidazo-pyridine derivatives

---

CA2492540C|2010-05-04|Modified pictet-spengler reaction and products prepared therefrom

---

DE69723846T2|2004-03-04|Process for the preparation of sildenafil

---

ES2513441T3|2014-10-27|Procedure for the preparation of pharmaceutically active compounds

---

US20090306388A1|2009-12-10|Method for substituted ih-imidazo[4,5-c] pyridines

---

US9822116B2|2017-11-21|Process and intermediates for the synthesis of 8-[{1-|phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds

---

US6943255B2|2005-09-13|Process for imidazo[4,5-c]pyridin-4-amines

---

TWI659016B|2019-05-11|Processes for preparing intermediates of substituted 5-fluoro-1h-pyrazolopyridines

---

US6743920B2|2004-06-01|Process for imidazo[4,5-c]pyridin-4-amines

---

JP6061158B2|2017-01-18|Synthesis intermediate of 6- | methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use

---

TW201609694A|2016-03-16|Process for the preparation of 3-|pyridine

---

US20060069085A1|2006-03-30|Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

---

CH633536A5|1982-12-15|METHOD FOR PRODUCING NEW tetracyclic piperidine or pyrrolidine.

---

JP2006206597A|2006-08-10|Method for producing substituted 2,5-diamino-3-hydroxyhexane

---

AU2006244635A1|2006-11-16|Ring closing and related methods and intermediates

---

EP1937683A1|2008-07-02|METHOD FOR 1H-IMIDAZOÝ4,5-c¨PYRIDINES AND ANALOGS THEREOF

---

TW201609696A|2016-03-16|Process for the preparation of 3-|pyridine

---

KR100882765B1|2009-02-09|Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative

---

SK111494A3|1995-06-07|Method of preparation of imidazopyridine derivatives

---

US7772276B2|2010-08-10|Exo-selective synthesis of himbacine analogs

---

HU204826B|1992-02-28|Process for producing imidazopyridine derivatives

同族专利:

---

公开号 | 公开日

---

DE60104704T2|2005-08-11|

---

UA73788C2|2003-06-16|

---

HK1054388B|2005-04-08|

---

HU0302277A2|2003-10-28|

---

NO20031046D0|2003-03-06|

---

HU225459B1|2006-12-28|

---

AT272637T|2004-08-15|

---

SK286717B6|2009-04-06|

---

SE0003186D0|2000-09-07|

---

AU8459401A|2002-03-22|

---

HK1054388A1|2005-04-08|

---

AU2001284594B2|2005-12-15|

---

EP1317455B1|2004-08-04|

---

EP1317455A1|2003-06-11|

---

US20090247755A1|2009-10-01|

---

WO2002020523A1|2002-03-14|

---

NZ524302A|2004-08-27|

---

NO20031046L|2003-05-05|

---

CN1452621A|2003-10-29|

---

HU0302277A3|2003-12-29|

---

PT1317455E|2004-11-30|

---

ZA200301171B|2004-03-18|

---

EP1317455B9|2004-11-17|

---

CN1255404C|2006-05-10|

---

NO324252B1|2007-09-17|

---

PL360626A1|2004-09-20|

---

US20060063797A1|2006-03-23|

---

EE05136B1|2009-02-16|

---

CA2419764C|2009-10-06|

---

IL154466D0|2003-09-17|

---

IS6728A|2003-02-26|

---

SK2702003A3|2003-08-05|

---

ES2223906T3|2005-03-01|

---

IL154466A|2009-06-15|

---

BR0113602A|2003-07-15|

---

CZ294957B6|2005-04-13|

---

JP4157766B2|2008-10-01|

---

IS2084B|2006-02-15|

---

DE60104704D1|2004-09-09|

---

KR100770478B1|2007-10-26|

---

EE200300090A|2004-12-15|

---

RU2275372C2|2006-04-27|

---

CA2419764A1|2002-03-14|

---

JP2004508371A|2004-03-18|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

法律状态:
2000-09-07|Priority to SE0003186A

---

2000-09-07|Priority to SE0003186-4

---

2001-09-05|Application filed by 아스트라제네카 아베

---

2001-09-05|Priority to PCT/SE2001/001897

---

2003-04-23|Publication of KR20030032011A

---

2007-10-26|Application granted

---

2007-10-26|Publication of KR100770478B1

优先权:

---

申请号 | 申请日 | 专利标题

---

SE0003186A|SE0003186D0|2000-09-07|2000-09-07|New process|

---

SE0003186-4|2000-09-07|

---

PCT/SE2001/001897|WO2002020523A1|2000-09-07|2001-09-05|Process for preparing a substituted imidazopyridine compound|